Stony Brook University | School of Medicine | Health Sciences Center
Jingfang Ju, PhD
Jingfang Ju, PhD 
Associate Professor
Co-director of Translational Research Laboratory
Basic Science Tower, Level 9
Stony Brook Medicine
Stony Brook, NY 11794-8691
Tel: (631) 444-2176
Fax: (631) 444-3424
E-mail: jingfang.ju@stonybrookmedicine.edu
Research Interests:
Dr. Ju’s research at Stony Brook University School of Medicine focuses on elucidating the mechanism of translational control mediated by miRNAs in cancer and translating the new discovery to clinical cancer diagnosis. His group is the first to discover that p53 regulates the expression of certain miRNAs, opening a new frontier in cancer research. Dr. Ju’s group is actively investigating the mechanism of miRNAs in proliferation, cell cycle control, chemoresistance to fluoropyrimidines and antifolates in tumor stem cells, and epithelial-to-mesenchymal transition. His group is also developing novel approaches to study post-transcriptional control mediated by miRNAs and RNA binding proteins. As for the translational research, they are interested in the investigation of miRNAs as biomarkers in cancer diagnosis and prognosis.
| Education: | ||||
| Institution and Location | Degree | Year(s) | Field of Study | |
| Northeastern University, P. R. China | B.S. | 1989 | Engineering | |
| Univ. of Southern California, Los Angeles, CA | Ph.D. | 1996 | Biochem/Mol. Bio | |
Positions and Employment: |
||||
| 1996-99 | Post-doctoral Fellow, Yale University School of Medicine | |||
| 1999-03 | Senior Research Scientist and Genomic Technology Team Leader, CuraGen Inc., CT | |||
| 2004-08 | Head of the Cancer Genomics, Assistant Professor of Oncological Sciences, Mitchell Cancer Institute | |||
| 2008-present | Co-Director of Translational Research, Department of Pathology, SBUMC, NY |
|||
| 2009-present | Graduate Faculty, Molecular and Cellular Biology Program, SBUMC, NY | |||
Other Experience and Professional Memberships (selected): |
||||
| 2011-present | Review Editor, Frontiers in Genomics Assay Technology | |||
| 2006-present | Editorial Board, Gene Regulation and Systems Biology | |||
| 2007-present | Editorial Board, Cancer Genomics and Proteomics | |||
| 2006 | Managing Editor, Frontiers in Biosciences | |||
| 2005-present | Member, American Society of Clinical Oncology | |||
| 2004-present | National Cancer Institute Study Section Member (Innovative Molecular Analysis Technology (IMAT), Applied Emerging Technology for Cancer Research, SBIR/STTR, Cancer Biomarker, BMCT, U-01, P-01) |
|||
| 2003-present | Member, Society of Chinese Bioscientists in America | |||
| 2000 | Stellar Achievement Award, CuraGen Corporation | |||
| 1999 | National Research Service Award, NIH | |||
| 1996 | Glaxo Welcome Young Clinical Research Scholar Award | |||
| 1992-present | Member, American Association for Cancer Research | |||
| 1991 | Scholarship from Los Alamos National Laboratory Science and Alliance Program | |||
Peer Reviewed Publications:
